financetom
Business
financetom
/
Business
/
What's Going On With NIO Stock Today?
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
What's Going On With NIO Stock Today?
May 26, 2025 5:12 AM

NIO Inc. ( NIO ) shares saw modest gains on Friday. The electric vehicle maker reportedly revealed plans to refresh several of its key models.

The company confirmed it will begin accepting pre-orders on Saturday, May 10, for updated versions of its ES6 SUV, EC6 coupe SUV, and its ET5 and ET5 Touring sedans, reports CnEV Post.

The report adds that NIO noted that showroom displays of the revamped ES6 and EC6 will be available across China starting May 10.

The EV firm reported 23,900 vehicle deliveries in April, marking a 53% jump year-over-year.

Also Read: These EV Makers Could Shine If Musk Leaves Tesla

Of those, 19,269 came from its flagship NIO brand, while 4,400 units were attributed to its family-focused line Onvo, and the remaining deliveries were early orders for its newest premium sub-brand, Firefly, officially launched in late April.

Last month, NIO’s Onvo unit made waves at the 2025 Shanghai Auto Show by unveiling its new large SUV, the L90.

The vehicle stands out with its spacious design, stretching over 5.1 meters in length and exceeding 3.1 meters in wheelbase. It targets families and comfort-focused buyers.

To date, as of April 30, 2025, NIO has delivered 737,558 vehicles cumulatively, demonstrating steady expansion across its growing brand portfolio.

According to Benzinga Pro, NIO stock has lost over 25% in the past year. Investors can gain exposure to the stock via Invesco Golden Dragon China ETF ( PGJ ) .

Price Action: NIO shares are trading higher by 0.88% to $4.005 at last check Friday.

Read Next:

Cathie Wood Says AI Will ‘Disrupt The Traditional World Order’ And Replace Search Engines Like Google

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Jazz Pharmaceuticals Says US FDA Granted Accelerated Approval for Modeyso
Jazz Pharmaceuticals Says US FDA Granted Accelerated Approval for Modeyso
Aug 6, 2025
03:52 PM EDT, 08/06/2025 (MT Newswires) -- Jazz Pharmaceuticals ( JAZZ ) said Wednesday that the US Food and Drug Administration granted accelerated approval for Modeyso, or dordaviprone, for the treatment of patients 1 year of age and older with recurrent H3 K27M-mutant diffuse midline glioma, a type of brain tumor. The FDA's decision was based on an integrated efficacy...
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Aug 17, 2025
SYDNEY, Aug 18 (Reuters) - Google agreed on Monday to pay a A$55 million ($35.8 million) fine in Australia after the consumer watchdog found it had hurt competition by paying the country's two largest telcos to pre-install its search application on Android phones, excluding rival search engines. The fine extends a bumpy period for the Alphabet-owned internet giant in Australia,...
-- Imperial Metals Brief: Says Judicial Review Petition Dismissed, Mount Polley to Continue Constructing TSF Raise
-- Imperial Metals Brief: Says Judicial Review Petition Dismissed, Mount Polley to Continue Constructing TSF Raise
Aug 6, 2025
03:56 PM EDT, 08/06/2025 (MT Newswires) -- Price: 3.96, Change: +0.01, Percent Change: +0.25 ...
US appeals court reinstates drug-price conspiracy lawsuit against Sanofi, rival pharma companies
US appeals court reinstates drug-price conspiracy lawsuit against Sanofi, rival pharma companies
Aug 6, 2025
Aug 6 (Reuters) - Drugmakers Sanofi, Eli Lilly ( LLY ), Novo Nordisk and AstraZeneca ( AZN ) must face a lawsuit from two health centers accusing them of conspiring to restrict drug discounts offered to community pharmacies that contract with providers serving low-income patients. A three-judge panel of the 2nd U.S. Circuit Court of Appeals in New York ruled...
Copyright 2023-2026 - www.financetom.com All Rights Reserved